Rigel Pharmaceuticals – Immune Thrombocytopenic Purpura

Submitted By:
Published Date:
January 25, 2020

Access Program Information

C-935788-055 is an open-label, multi-center, expanded access (EAP) study.

Rare Disease:
Retinitis pigmentosa